Logo

Nanosphere Shares Fall for Second Straight Day

Aug 18, 2008
NEW YORK (GenomeWeb News) – Shares of Nanosphere were down 6.1 percent at $9.09 in Monday afternoon trading on the Nasdaq, marking the second day in a row that its stock tumbled since it reported a 62 percent decrease in second-quarter revenues last week.
 
The Northbrook, Ill.-based molecular diagnostics firm reported last Thursday that its second-quarter revenue dropped to $195,000 from $510,000 in the second quarter of 2007. The firm also said that its net loss grew 17 percent year over year.
 
In Friday trade, Nanosphere’s stock fell 14.6 percent to close at $9.68.
 
The firm’s stock is trading well off a 52-week high of $22.04, which was reached in November 2007. Its 52-week low is $6.62, which it hit on May 5.

Breaking News
The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.